To verify if methyltransferase activity is required for ASH1L’s role in promoting cancer invasiveness, we constructed a catalytically inactive mutant of ASH1L-F3, F2260A16,32, and then introduced it into LNCaP cells (Supplementary Fig. 3m). Here, ASH1L is linked to cancer.